Four Cycles of Docetaxel Plus Cisplatin as Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy in Stage N2–3 Nasopharyngeal Carcinoma: A Phase 3 Multicenter Randomized Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3987072 ◽

2021 ◽

Author(s):

Wei-Hao Xie ◽

Hui Chang ◽

Qiao-Xuan Wang ◽

Yan Yuan ◽

Ming-Jun Xu ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Nasopharyngeal Carcinoma ◽

Neoadjuvant Chemotherapy ◽

Concurrent Chemoradiotherapy ◽

Controlled Trial ◽

Phase 3 ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial

Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial

International Journal of Cancer ◽

10.1002/ijc.32099 ◽

2019 ◽

Vol 145 (1) ◽

pp. 295-305 ◽

Cited By ~ 38

Author(s):

Wen‐Fei Li ◽

Nian‐Yong Chen ◽

Ning Zhang ◽

Guo‐Qing Hu ◽

Fang‐Yun Xie ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Nasopharyngeal Carcinoma ◽

Induction Chemotherapy ◽

Concurrent Chemoradiotherapy ◽

Controlled Trial ◽

Long Term Results ◽

Phase 3 ◽

Randomized Controlled

Nutritional Results After Target Volume Reduction Of Intensity-Modulated Radiotherapy Following Induction Chemotherapy In Locoregionally Advanced Nasopharyngeal Cancer: A Phase 3, Multicenter, Randomized Controlled Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.290 ◽

2020 ◽

Vol 108 (3) ◽

pp. e803

Author(s):

L. Xiang ◽

J. Wu

Keyword(s):

Randomized Controlled Trial ◽

Induction Chemotherapy ◽

Controlled Trial ◽

Nasopharyngeal Cancer ◽

Intensity Modulated Radiotherapy ◽

Target Volume ◽

Phase 3 ◽

Intensity Modulated ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial

A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update

Current Problems in Cancer ◽

10.1016/j.currproblcancer.2019.06.007 ◽

2020 ◽

Vol 44 (1) ◽

pp. 100492

Author(s):

Yuanyuan Li ◽

Ye Tian ◽

Feng Jin ◽

Weili Wu ◽

Jinhua Long ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Controlled Trial ◽

Locally Advanced ◽

Long Term Outcomes ◽

Recombinant Human Endostatin ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial

Fixed combination of tazarotene and betamethasone dipropionate for treatment of psoriasis vulgaris: The result of a phase 3, multicenter, randomized controlled trial

The Journal of Dermatology ◽

10.1111/1346-8138.15349 ◽

2020 ◽

Vol 47 (7) ◽

pp. 728-734

Author(s):

Hao Chen ◽

Jianfang Sun ◽

Haizhen Yang ◽

Qiuning Sun ◽

Jianzhong Zhang ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Psoriasis Vulgaris ◽

Fixed Combination ◽

Controlled Trial ◽

Betamethasone Dipropionate ◽

Phase 3 ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial

Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE)

BMC Cancer ◽

10.1186/s12885-018-4466-7 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 4

Author(s):

Chang Woo Kim ◽

Byung Mo Kang ◽

Ik Yong Kim ◽

Ji Yeon Kim ◽

Sun Jin Park ◽

...

Keyword(s):

Rectal Cancer ◽

Randomized Controlled Trial ◽

Concurrent Chemoradiotherapy ◽

Controlled Trial ◽

Locally Advanced ◽

Low Rectal Cancer ◽

Consolidation Chemotherapy ◽

Korean Society ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial

Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open‐label, randomized controlled trial

Cancer ◽

10.1002/cncr.34074 ◽

2021 ◽

Author(s):

Leifeng Liang ◽

Zhibing Liu ◽

Haisheng Zhu ◽

Hongqian Wang ◽

Yan Wei ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Nasopharyngeal Carcinoma ◽

Oral Mucositis ◽

Concurrent Chemoradiotherapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Open Label ◽

Randomized Controlled

Platelet-Derived Growth Factor Stimulates Bone Fill and Rate of Attachment Level Gain: Results of a Large Multicenter Randomized Controlled Trial

Yearbook of Dentistry ◽

10.1016/s0084-3717(08)70367-2 ◽

2007 ◽

Vol 2007 ◽

pp. 87-88

Author(s):

A. Dentino

Keyword(s):

Randomized Controlled Trial ◽

Growth Factor ◽

Controlled Trial ◽

Platelet Derived Growth Factor ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial ◽

Attachment Level

Are Day Hospitals Effective for Acutely III Psychiatric Patients? A European Multicenter Randomized Controlled Trial

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)70730-8 ◽

2008 ◽

Vol 2008 ◽

pp. 147-148

Author(s):

J.A. Talbott

Keyword(s):

Randomized Controlled Trial ◽

Psychiatric Patients ◽

Controlled Trial ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial ◽

Day Hospitals

Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results

10.26226/morressier.5aeaf2d35800a00019097f88 ◽

2018 ◽

Author(s):

Jürgen K. Rockstroh ◽

Christian Wisskirchen

Keyword(s):

Randomized Controlled Trial ◽

Protease Inhibitor ◽

Controlled Trial ◽

Fixed Dose ◽

Phase 3 ◽

Randomized Controlled ◽

Tenofovir Alafenamide

Fit-for-Fertility Multicenter Randomized Controlled Trial

Case Medical Research ◽

10.31525/ct1-nct03908099 ◽

2019 ◽

Author(s):

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial